AVRMDMedical XR Network
Back to stage
Technical problem

Showing benefit that outlasts the headset

Many VR studies measure change during or just after exposure. Evidence that effects persist weeks later, especially for chronic conditions, is thinner and inconsistent, which limits clinical and payer confidence.

StageClinical validation
Addressed by

Nothing in the catalog addresses this yet

This is a real gap rather than a missing page. If you know work that addresses it, suggest a record.

Provenance

Where this problem statement comes from

Journal of Pain Research — VR as an analgesic for acute and chronic pain: systematic reviewReview concludes VR reliably reduces acute pain but evidence for lasting chronic-pain relief is insufficient, with heterogeneous populations and doses. The problem statement is AVRMD's framing; the cited work documents the difficulty.